Merck exec: Health IT apps need more scientific rigor

When Merck ($MRK) was deciding where to base its digital innovation unit, Boston's health IT startup ecosystem made it the obvious candidate. Yet the Merck executive leading the unit has warned that the city's startups can still improve, particularly with regards to the degree of scientific rigor applied to their apps. Article

Suggested Articles

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

Eric Perakslis' experience with Takeda will help facilitate a new collaboration between the two companies.

The $58 million financing round represents biopharma industry's growing interest in genomics data.